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Introduction: Pulmonary nodules of the adenocarcinoma spectrum 
are characterized by distinctive morphological and radiologic fea-
tures and variable prognosis. Noninvasive high-resolution computed 
tomography–based risk stratification tools are needed to individual-
ize their management.
Methods: Radiologic measurements of histopathologic tissue inva-
sion were developed in a training set of 54 pulmonary nodules of the 
adenocarcinoma spectrum and validated in 86 consecutively resected 
nodules. Nodules were isolated and characterized by computer-aided 
analysis, and data were analyzed by Spearman correlation, sensitiv-
ity, and specificity and the positive and negative predictive values.
Results: Computer-aided nodule assessment and risk yield 
(CANARY) can noninvasively characterize pulmonary nodules of 
the adenocarcinoma spectrum. Unsupervised clustering analysis of 
high-resolution computed tomography data identified nine unique 
exemplars representing the basic radiologic building blocks of these 
lesions. The exemplar distribution within each nodule correlated well 
with the proportion of histologic tissue invasion, Spearman R = 0.87, 
p < 0.0001 and 0.89 and p < 0.0001 for the training and the vali-
dation set, respectively. Clustering of the exemplars in three-dimen-
sional space corresponding to tissue invasion and lepidic growth was 
used to develop a CANARY decision algorithm that successfully 
categorized these pulmonary nodules as “aggressive” (invasive ade-
nocarcinoma) or “indolent” (adenocarcinoma in situ and minimally 
invasive adenocarcinoma). Sensitivity, specificity, positive predictive 
value, and negative predictive value of this approach for the detection 
of aggressive lesions were 95.4, 96.8, 95.4, and 96.8%, respectively, 
in the training set and 98.7, 63.6, 94.9, and 87.5%, respectively, in 
the validation set.
Conclusion: CANARY represents a promising tool to noninvasively 
risk stratify pulmonary nodules of the adenocarcinoma spectrum.
Key Words: Computer-aided image analysis, Lung adenocarcinoma, 
Pulmonary nodules, Risk stratification.
(J Thorac Oncol. 2013;8: 452-460)
Lung cancer remains the leading cause of cancer-related deaths in the United States and worldwide.1,2 Although early 
diagnosis offers a chance of cure, in the absence of effective 
screening, most patients present with advanced stage disease 
associated with poor outcomes.3 Recently, the National Lung 
Screening Trial (NLST) demonstrated that annual screening 
using low-dose chest high-resolution computed tomography 
(HRCT) reduces lung cancer–specific mortality by 20% in 
high-risk individuals. Unfortunately, computed tomography 
(CT) screening was positive in 39.1% of all participants and 
24.2% of all screening CT scans. The false-positive rate was 
96.4% among all positive screening CTs.4
Data from previous single-arm observational studies 
of lung cancer screening suggest that some HRCT screen–
detected lung cancers may be more indolent than their clini-
cally detected counterparts. The majority of these lesions 
belong to the recently reclassified lung adenocarcinoma 
spectrum.5–7 The radiologic manifestations of these lesions 
range from pure ground glass opacities (GGO) to sub-
solid opacities (SSO) and solid pulmonary nodules (SPN). 
Although GGO and SSO typically progress slowly as evi-
denced by prolonged volume-doubling times of frequently 
more than 400 days, SPN of the adenocarcinoma spectrum 
often grow faster.5
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Histologically, GGO and SSO are usually character-
ized by various combinations of lepidic growth (malignant 
growth along the intact alveolar structures), tissue inva-
sion, and associated desmoplasia. Therefore, depending on 
the presence and size of invasive foci, they are classified as 
adenocarcinoma in situ (AIS), minimally invasive adenocar-
cinoma (MIA, invasion ≤5 mm), or invasive adenocarcinoma 
(IA, invasion >5 mm). In contrast, enlarging solid areas and 
SPN on HRCT typically represent IA.8 Although the clinical 
outcomes of patients with surgically resected AIS and MIA 
are excellent (approaching 100% disease-specific survival at 
10 years), patients with IA have a more guarded prognosis.9–11 
This spectrum of biological behavior highlights the value of 
a comprehensive histologic examination of these lesions to 
predict patient outcomes and forms the basis of the recent his-
tologic reclassification of the lung adenocarcinoma spectrum. 
Because alternative therapeutic strategies to standard lobec-
tomy (such as sublobar resections) are currently being investi-
gated, the noninvasive risk stratification of these nodules will 
facilitate individualized patient management. Currently, this 
assessment requires surgical resection of the lesion with his-
topathologic examination of the entire lesion, which cannot be 
reliably performed on nonsurgical tissue biopsies. Because of 
the widespread availability and utilization of HRCT in clini-
cal practice and lung cancer screening programs, HRCT-based 
risk stratification would be ideal for this task. Unfortunately, 
currently available HRCT-based strategies remain suboptimal.
Computer-aided lung informatics for pathology evalu-
ation and rating (CALIPER) is a HRCT-based image analy-
sis tool developed at Mayo Clinic, Rochester, Minnesota. 
CALIPER has demonstrated considerable potential for auto-
matic, rapid, and reliable lung parenchymal isolation and tis-
sue classification in patients with diffuse lung diseases such as 
diffuse interstitial pneumonias and emphysema.12 On the basis 
of these observations, we hypothesized that CALIPER could 
facilitate the noninvasive radiologic–pathologic correlation of 
pulmonary nodules of the adenocarcinoma spectrum. Herein, 
we report the development of computer-aided nodule assess-
ment and risk yield (CANARY)—an adjunct tool for the char-
acterization and categorization of pulmonary nodules (Fig. 1).
MATERIALS AND METHODS
Participants
Between 2008 and 2010, patients with surgically 
resected lesions of the pulmonary adenocarcinoma spectrum 
(search terms “bronchioloalveolar carcinoma (BAC),” “ade-
nocarcinoma with BAC features,” and “adenocarcinoma”) 
were identified from the Mayo Clinic Epidemiology and 
Genetics of Lung Cancer Study database as a training set. An 
independent validation set of 86 pulmonary nodules of the 
adenocarcinoma spectrum consecutively resected from 80 
patients (from January 1, 2006 to December 31, 2007) pulmo-
nary nodules of adenocarcinoma spectrum meeting the same 
inclusion criteria as the training set were identified from the 
Mayo Clinic Thoracic Surgery Registry. All patients without a 
signed research authorization were excluded.
Histology Review
Two independent expert pulmonary pathologists (J.B. 
and E.S.Y.) blindly (without clinical or radiologic informa-
tion) reviewed all available hematoxylin and eosin slides of 
the enrolled cases. Because the proportion of lepidic growth 
was found to be technically easier to estimate the proportion 
of invasion, they estimated the proportion of lepidic growth. In 
addition, the presence or absence of stromal, vascular, and/or 
pleural invasion was assessed, and the diameter of the largest 
area of invasion, including surrounding scar, was measured. 
All measurements were adjusted to the nearest millimeter.
On the basis of the largest focus of tissue invasion, all 
cases were also categorized as absent invasion (AIS), less 
than or equal to 5 mm invasion (MIA), or greater than 5 mm 
invasion (IA), as previously described.11 When there was dis-
agreement between invasive category (AIS, MIA, and IA), 
the consensus invasive category was determined by the third 
pathologist (M.C.A.). The consensus value for the proportion 
of lepidic growth was determined using the following algo-
rithm (all values in cases where lepidic growth was <90% 
were rounded up to the nearest 10%):
For cases less than 50% lepidic growth by either pathol-
ogist, the results were averaged if the discrepancy was less 
than or equal to 20%. Otherwise, a third pathologist reviewed 
the case, and the two closest lepidic growth values were aver-
aged. For cases between 50 and 90% lepidic growth, the 
results were averaged if the discrepancy was less than or equal 
to 10%. Otherwise, a third pathologist reviewed the case, and 
the two closest lepidic growth values were averaged. Cases 
greater than or equal to 90% lepidic growth were categorized 
as 90, 95, 99, or 100% by two pathologists. Any discrepant 
cases were reviewed by a third pathologist and categorized 
based on the two closest values.
CT Imaging
Chest CT scans were performed on a variety of scan-
ners. The scanners were all multidetector scanners ranging 
from 8 to 64 detectors. Preoperative (≤3 months) thin section 
images were required in all cases. Collimation ranged from 
1.25 to 2.5 mm. Reconstruction algorithms varied by scanner 
and included both smoothing and high-resolution algorithms 
based on the vendor algorithms.
Radiology Review
All preoperative CT scans included in the training set 
were reviewed independently in a blinded fashion by two 
thoracic radiologists (A.M.S. and T.E.H.). Both readers sub-
jectively categorized each case as aggressive or indolent and 
measured the tumor/consolidation (C/T) ratio as previously 
described.13
Lung Parenchymal Characterization 
and Nodule Extraction
Lung parenchymal isolation and classification
The lung parenchyma was isolated by segmentation 
of preoperative HRCT data using an adaptive density-based 
morphology approach involving threshold optimizing, region 
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growing, and hole filling. Lung parenchymal classification 
was based on the previously identified exemplars representing 
five radiologic lung tissue types: normal, emphysema, reticu-
lar, ground glass, and honeycomb change. An exemplar repre-
sents the most central region of interest (ROI) within a natural 
cluster of ROIs and constitutes the basic building block for 
the CALIPER-based lung parenchymal classification. These 
exemplars were derived based on the statistical analysis of rep-
resentative HRCT data of patients with various parenchymal 
lung diseases that were selected from the Lung Tissue Research 
Consortium.12 Consequently, each lung parenchymal voxel 
was assigned to one of these five primal lung parenchymal 
HRCT patterns using CALIPER (See Supplemental Figures 
1 [Supplemental Digital Content 1, http://links.lww.com/JTO/
A389] and 2 [Supplemental Digital Content 2, http://links.
lww.com/JTO/A390] and Supplemental Table 1 [Supplemental 
Digital Content 3, http://links.lww.com/JTO/A391]).
Nodule extraction
The location of all surgically resected nodules was 
known a priori. Hence, the nodule of interest was extracted 
with a supervised approach using constrained seeded region 
growing. Because GGO, SSO, and SPN nodules are composed 
of reticular and ground glass patterns, the region growing was 
constrained to include only those voxels connected to the seed 
voxel and classified as reticular or ground glass.
Statistical Analysis
Multinomial logistic regression was used to generate 
equations predictive of the degree of histologic invasion (see 
Results section).
Because of the lack of a Gaussian distribution of the 
data for AIS and invasion, nonparametric Spearman correla-
tion was used to analyze the relationship between histopatho-
logic and radiologic invasion as determined by CANARY. The 
sensitivity, specificity, and the positive and negative predic-
tive value for CANARY to distinguish histopathologically 
“aggressive” from “indolent” lesions were calculated. A p 
value of less than 0.05 was considered statistically significant. 
Cohen’s kappa was calculated as a statistical measure of the 
inter-rater agreement between the thoracic radiologists. The 
Prism software package (GraphPad, San Diego, CA) was used 
for the statistical analysis.
The Mayo Foundation Institutional Review Board 
approved the study.
RESULTS
Subjects
For the training set, 139 of the 208 identified cases were 
excluded because of the lack of an appropriate preoperative 
HRCT scan. Of the remaining 70 patients, 16 patients with 
lung masses (>3 cm) were excluded. Fifty-four patients with 
surgically resected pulmonary nodules of the adenocarcinoma 
spectrum were included in the analysis as the training set.
For the independent validation set, 86 nodules (80 
patients) of consecutively resected pulmonary nodules with 
similar inclusion criteria as the training set were included in 
the analysis. The demographic characteristics, tumor, node, 
metastasis stage, pathologic nodule size, and consensus histo-
pathology diagnoses for these patients are included in Table 1 
and Supplemental Figure 3 (Supplemental Digital Content 4, 
http://links.lww.com/JTO/A392).
Radiologic nodule analysis and development of 
CANARY
Conventional characterization of lung nodules on 
HRCT consists of semiquantitative estimates of the solid and 
ground glass components by a trained radiologist. However, 
these nodules are represented by a complex combination of 
numerous contiguous voxels with a broad range of densities. 
Consequently, reducing this information to only two catego-
ries, solid or ground glass, likely results in the loss of poten-
tially useful diagnostic information. Using CANARY, we 
were able to successfully reduce this complex pattern of voxel 
densities to a limited number of representative exemplars, 
hypothesized to represent the essential building blocks of lung 
nodules of the adenocarcinoma spectrum. These exemplars 
were generated using the following approach. An expert tho-
racic radiologist (B.J.B.) arbitrarily selected 774 ROI (size = 
9 × 9 voxels, Fig. 2) spanning the radiologic spectrum of these 
lesions across the HRCT scans of 37 randomly selected cases 
(37 of the 54 included cases). Natural clusters among these 
ROIs were identified by comparing all ROIs to one another 
using affinity propagation (an unsupervised clustering tech-
nique) and pairwise similarity metrics.14 This unsupervised 
analysis yielded nine unique natural clusters of ROIs. The most 
TABLE 1.  Patient Demographics, Tumor Stage, Nodule Size, 
and Histology 
Demographics
54 patients  
(n = 54 nodules) 
training set
80 patients  
(n = 86 nodules) 
validation set
Age at diagnosis  
years: median (range)
68 (40–89) 68 (35–91)
Gender n (%)
 Women 35 (65) 48 (60)
 Smoking n (%)
 Never 17 (31) 9 (11)
TNM stage n (%)
 IA 42 (76) 42 (52)
 IB 1 (2) 12 (15)
 IIA 0 4 (5)
 IIB 8 (16) 7 (9)
 IIIA 1 (2) 8 (10)
 IV 2 (4) 7 (9)
 Nodule size mm ± SD 16.7 ± 0.69 17.2 ± 0.61
Histopathologic  
classification n (%)
 AIS 2 (6) 1 (1)
 MIA 20 (36) 10 (12)
 IA 32 (58) 75 (87)
AIS, adenocarcinoma in situ; IA, invasive adenocarcinoma; MIA, minimally 
invasive adenocarcinoma; TNM, tumor, node, metastasis.
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central ROI within each cluster was chosen as the exemplar, 
or essential building block, of the lesions (see Supplemental 
Material, Supplemental Digital Content 5, http://links.lww.
com/JTO/A393). These exemplars were color coded as Violet 
(V), Indigo (I), Blue (B), Green (G), Yellow (Y), Orange (O), 
Red (R), Cyan (C), and Pink (P). These color-coded exem-
plars form the basic building blocks for the analysis and risk 
stratification of pulmonary nodules of the adenocarcinoma 
spectrum by CANARY (Fig. 2).
To characterize an extracted lung nodule, each voxel 
within the nodule was compared with all nine exemplars. The 
most similar exemplar was computed using the pairwise com-
parison of histograms of the 9 × 9 voxel neighborhood of each 
voxel to the respective exemplars. The color code of the most 
similar exemplar was assigned to each individual voxel of the 
analyzed nodule. This approach resulted in a specific combi-
nation of exemplars (and color pattern) for each nodule. This 
distribution of exemplars within the nodule (signature) was 
visualized yielding concentric color-coded areas (Fig. 3A). 
Hence, CANARY signatures were established without clinical 
input, solely based on radiologic characteristics.
CANARY-based assessment of the relative contribu-
tions of tissue invasion and lepidic growth in pulmo-
nary nodules of the adenocarcinoma spectrum
To investigate the face validity of the CANARY lung 
nodule signatures, we attempted to determine whether spe-
cific signatures (combination of exemplars) would correlate 
with distinct histologic characteristics. We elected to compare 
these radiologic signatures to a histologic measure of inva-
sion defined as 100%—lepidic growth %. Sixteen nodules 
spanning the entire spectrum of invasion (from 0 to 100% as 
assessed by consensus pathology) were included in a multi-
nomial logistic regression analysis to generate equations to 
radiologically predict the proportion of histologic tissue inva-
sion. These predictive equations were then validated on the 
FIGURE 1.  CANARY workflow outlining the procedural steps 
involved in categorizing the HRCT-based nodules into one 
of AIS, MIA, and IA. The first step involves the automated 
lung parenchymal isolation and classification using CALIPER. 
Subsequently, each nodule is identified by the operator using 
seed placement. This is followed by the automated volumet-
ric extraction of the nodule and the characterization of each 
voxel within a given nodule based on the nine exemplars. 
This distribution of the exemplars within an individual lesion 
is then used to categorize each nodule. AIS, adenocarcinoma 
in situ; CALIPER, computer-aided lung informatics for pathol-
ogy evaluation and rating; CANARY, computer-aided nodule 
assessment and risk yield; HRCT, high-resolution computed 
tomography; IA, invasive adenocarcinoma; MIA, minimally 
invasive adenocarcinoma.
FIGURE 2.  Natural clustering of HRCT 
regions of interest (ROI) of lung nodules. 
(A) Representative ROIs selected from dif-
ferent nodules in the training set. Each of 
the 774 ROI was compared with each other 
to derive the pairwise 774 × 774 similarity 
matrix and color coded (B) such that the 
darkness is proportional to the similarity. 
(C) Similarity matrix in the affinity propa-
gation–based clustered space wherein the 
arbitrarily color-coded diagonal sub-blocks 
show the automatically computed natural 
clusters. HRCT, high-resolution computed 
tomography.
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remaining 38 nodules. In addition, the excellent correlation 
between CANARY and consensus histopathology was con-
firmed in an independent validation set (Fig. 4).
With the exception of two cases, correlation between 
CANARY and consensus histopathology was excellent 
(Spearman R = 0.87, 95% confidence intervals [CI]: 0.78–0.92; 
p < 0.0001) among the 38 cases of the training set and even 
better, Spearman R = 0.89, CI: 0.83–0.93; p < 0.0001, in the inde-
pendent validation set of 86 nodules from 80 patients (Fig. 4).
The two discrepant cases were reviewed in detail. For 
one case, CANARY determined the lesion to be 100% inva-
sive, whereas consensus histologic assessment found no inva-
sion. For the second case, CANARY measured 80% invasion 
compared with 20% by consensus histology. These cases were 
FIGURE 3.  Representative signatures 
for invasive adenocarcinoma (IA), mini-
mally invasive adenocarcinoma (MIA), 
and adenocarcinoma in situ (AIS) (A). 
Representative CT images with the super-
imposed distribution of the nine adeno-
carcinoma exemplars are shown for IA, 
MIA, and AIS. (B) Three-dimensional 
distribution of the nine adenocarcinoma 
exemplars using multidimensional scaling. 
It demonstrates the secondary clustering of 
the exemplars; violet–indigo–red–orange 
(V-I-R-O) representing invasion, yellow–
pink (Y-P) and blue–green–cyan (B-G-C) 
representing lepidic growth. CT, computed 
tomography.
FIGURE 4.  Radiologic–histopathologic 
correlation of tissue invasion between 
CANARY-based nodule assessment and 
consensus histopathology. Examples of rep-
resentative CT images with superimposed 
CANARY “signatures” (distinctive combina-
tions of exemplars within one nodule) asso-
ciated with nodules with varying degrees 
of histologic invasion (%, 100—consensus 
histopathology lepidic growth %) (A). 
Correlation between CANARY and consen-
sus histopathology for pulmonary nodules 
of the adenocarcinoma spectrum, training 
set, excluding 16 cases used to develop 
CANARY (n = 38) (B) and validation set 
(n = 86) (C). Spearman correlation (p < 
0.0001), line represents linear regression (B 
and C). CANARY, computer-aided nodule 
assessment and risk yield; CT, computed 
tomography.
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found to be solid opacities radiologically, although charac-
terized by minimal invasion on histopathologic evaluation, 
explaining the discordant results between CANARY assess-
ment and histopathology.
CANARY-based noninvasive radiologic risk stratifi-
cation of pulmonary nodules of the adenocarcinoma 
spectrum
Subsequently, multidimensional scaling was used to 
understand the three-dimensional distribution of the nine adeno-
carcinoma exemplars.15 The space partitioned into three natural 
exemplar clusters corresponding to the V-I-R-O, Y-P, and B-G-C 
exemplars. The quantitative distribution of the different exem-
plars and the rule-based CANARY decision algorithm were 
used to categorize each of the pulmonary nodules. On the basis 
of the observation that V-I-R-O and B-G-C groups correlated 
predominantly with invasion and lepidic growth, respectively, 
a rule-based CANARY decision algorithm was developed to 
categorize every nodule as AIS, MIA, or IA. (Figs. 3B and 5)
Patients with AIS and MIA share a similarly favorable 
postsurgical prognosis. This contrasts with the worse postop-
erative survival of patients with IA. Consequently, we classi-
fied all cases as either Group 1 histology aggressive (n = 32, 
training set and n = 75, validation set; IA) or Group 2 histology 
indolent (n = 22, training set and n = 11, validation set; AIS 
and MIA) based on predominance of the VIRO (aggressive), 
YP (moderately aggressive), or the BGC (indolent) cluster. 
Sensitivity, specificity, positive predictive value, and negative 
predictive value for the detection of histopathologic aggressive 
lesions using the CANARY decision algorithm were calcu-
lated. The sensitivity was 95.4% (95% CI: 75.1–99.7%) and 
98.7% (95% CI: 91.8–99.9%), the specificity was 96.8% (95% 
CI: 82–99.8%) and 63.6% (95% CI: 31.6–87.6%), the positive 
predictive value was 95.4% (95% CI: 75.1–99.7%) and 94.9% 
(95% CI: 86.7–98.3%), and the negative predictive value was 
96.8% (95% CI: 82–99.8%) and 87.5% (95% CI: 46.7–99.3%) 
in the training and validation set, respectively (Fig. 6).
None of the indolent cases identified by CANARY in the 
training or validation sets presented with locally advanced of 
metastatic disease. In the validation set, lung cancer–specific 
postsurgical survival of the indolent and aggressive CANARY 
groups mirrored that of the AIS/MIA and IA groups identified 
by consensus histopathology (Fig. 7).
Semiquantitative Review of the Training Set
On the basis of the case review by the treating physician, 
the assessment of the clinical radiologist, and patient prefer-
ences, all 140 nodules included in the training and validation 
sets were judged to be worrisome enough to be resected. All 
54 preoperative CT scans analyzed by CANARY in the train-
ing set were reviewed independently in a blinded fashion by 
two thoracic radiologists (A.M.S. and T.E.H.). Both readers 
subjectively categorized each case as aggressive (IA) or indo-
lent (AIS or MIA). There was moderate agreement with a κ 
of 0.49 (95% CI: 0.21–0.78). On the basis of consensus his-
tology, 36 cases were correctly categorized by both radiolo-
gists. In 10 cases, the readers disagreed and eight cases were 
incorrectly classified by both. Seven cases were classified as 
aggressive as opposed to indolent and one case as indolent 
as opposed to aggressive. Representative cases misclassified 
by both radiologists but correctly identified by CANARY are 
shown in Figure 8.
FIGURE 5.  Rule-based CANARY decision algorithm based on 
the distribution of exemplar clusters (%): violet–red–orange 
(VIRO), yellow–pink (YP), and blue–green–cyan (BGC) within 
each lesion. CANARY, computer-aided nodule assessment and 
risk yield.
FIGURE 6.  Two by two contingency table of CANARY’s diagnostic performance (rows) to predict consensus histopathologic tissue 
invasion (columns). (A) Training set (n = 54). (B) Validation set (n = 86). CANARY, computer-aided nodule assessment and risk yield.
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Using a C/T ratio of less than or equal to 0.25 to clas-
sify the pulmonary nodules as indolent (≤0.25) or aggressive 
(>0.25), we observed better agreement (substantial agree-
ment), κ = 0.78 (95% CI: 0.60–0.96) between the two readers. 
In the training set, a C/T ratio less than or equal to 0.25 by 
consensus or average between the two readers detected inva-
sion with a sensitivity of 91% (95% CI: 74–98%) and a speci-
ficity of 55% (95% CI: 33–75%).
DISCUSSION
The ever-increasing utilization of HRCT imaging of 
the lungs has led to a substantial increase in the number of 
detected pulmonary nodules. In addition, the results of the 
recently published NLST will almost certainly prompt the 
implementation of comprehensive HRCT screening pro-
grams for high-risk individuals. This strategy has already 
been endorsed by some of the major medical societies.4,16 
Pulmonary nodules of the adenocarcinoma spectrum repre-
sent the majority of HRCT-detected lung cancers, and the 
biological behavior of a subgroup of these lesions seems to 
differ significantly from their clinically detected counter-
parts, although arguably the data regarding the natural history 
of these lesions are limited.5 Radiologically, these lesions 
often present as solitary or not uncommonly multiple SSO 
or pure GGO, for which the optimal management strategies 
are suboptimally defined. Consequently, the indiscriminate 
implementation of a mass HRCT screening program and 
routine utilization of standard surgical therapy (lobectomy) 
as opposed to currently available alternatives such as lim-
ited resection or stereotactic body radiation therapy would 
potentially result in excess mortality, morbidity, and health 
care cost. This paradigm shift in our understanding of lung 
cancer will require the urgent development and implementa-
tion of new noninvasive strategies for the risk stratification 
and guidance of the individualized management of HRCT-
detected pulmonary nodules.13
Unsupervised CANARY-based analysis of HRCT data 
identified nine exemplars across the spectrum of pulmonary 
nodules of the lung adenocarcinoma spectrum. These exem-
plars segregate into three clusters that seem to visually cor-
respond to the predominant histopathology of the lesion. 
Although the B-G-C cluster represents lepidic growth, the 
V-I-R-O cluster correlates with tissue invasion. By providing 
additional HRCT descriptors beyond well-established catego-
ries such as GGO and consolidation, CANARY-based analysis 
facilitates the individualized characterization of pulmonary 
nodules of the lung adenocarcinoma spectrum. On the basis 
of the CANARY analysis and the consensus histopathology of 
the lesion, we successfully designed and optimized a decision 
algorithm for the noninvasive risk stratification into aggressive 
FIGURE 7.  Lung cancer–specific post-
operative survival. (A) Consensus histo-
pathology and (B) CANARY. CANARY, 
computer-aided nodule assessment and 
risk yield.
FIGURE 8.  Representative nodules with discrepant radiologic and histologic classification. Nodules in (A) and (B) were cat-
egorized differently by the expert radiologists (IA versus MIA) but correctly identified by CANARY (histologic consensus MIA). 
Histology confirmed MIA nodules in (C) and (D) were categorized by both radiologists as IA. The histologically confirmed IA 
nodule in (E) was categorized by both the radiologists as MIA. The rule-based CANARY categorization of these nodules was the 
same as histology consensus. CANARY, computer-aided nodule assessment and risk yield; IA, invasive adenocarcinoma; MIA, 
minimally invasive adenocarcinoma.
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(IA) and indolent lesions (AIS and MIA). Through automated 
volumetric quantitation of the lesions, CANARY provides the 
opportunity for the noninvasive preoperative characterization 
and risk stratification of pulmonary nodules of the lung adeno-
carcinoma spectrum. If validated in future prospective studies, 
CANARY could ultimately become a valuable tool to assist in 
the individualized management of these lesions (e.g., limited 
surgical resection versus standard of care).17
Other investigators have successfully demonstrated the 
value of comprehensive histologic assessment to predict the 
postsurgical disease-specific survival (biological behavior) of 
these pulmonary nodules. In this context, pure lepidic growth 
(AIS) and less than or equal to 5 mm invasion (MIA) are asso-
ciated with significantly better patient outcomes than lesions 
with greater than 5 mm invasion (IA).10,18–23 These observa-
tions are reflected in the revised 2011 histologic classification 
of pulmonary adenocarcinomas.11 Unfortunately, compre-
hensive histologic tumor tissue analysis requires the surgi-
cal removal of the lesion and is not feasible for preoperative 
treatment planning. In contrast, HRCT allows the comprehen-
sive and noninvasive characterization of pulmonary nodules. 
However, the accurate and reproducible assessment of pul-
monary nodules, including solid opacities and SSO, remains 
challenging. Difficulties include large interobserver variabil-
ity in the assessment of simple variables such as variation of 
size over time to estimates of volume-doubling times. Despite 
previous reports demonstrating some correlation between lep-
idic growth and tissue invasion with GGO and SSO by HRCT, 
respectively, these strategies remain not well defined.19,24–28
Previously reported semiquantitative strategies to char-
acterize pulmonary nodule–evaluated characteristics of these 
lesions include diameter, area, modified diameter (consoli-
dation to GGO ratio), and the vanishing ratio (portion of the 
nodule that remains visible from parenchymal to mediastinal 
windows).13,29,30 Although initial studies suggested that the 
vanishing ratio might be the most reliable parameter to char-
acterize these lesions, a recently published large prospective 
study of 545 patients demonstrated that the C/T ratio might 
represent a better predictor in a Japanese patient population.31 
In this study, a C/T ratio more than 0.25 predicted the pres-
ence of IAs among nodules less than or equal to 2 cm with a 
sensitivity of 98.7% (78/79, 95% CI: 93.2–100%) but with a 
specificity of 16.2% (34/210, 95% CI: 11.5–21.9%).
In contrast to automated computer-aided strategies such 
as CANARY, intra- and interobserver variability remains a 
significant issue for the subjective classification and opera-
tor driven semiquantitative measurements of these lesions. 
This was confirmed in our study, as we observed only mod-
erate agreement between two expert thoracic radiologists for 
the subjective classification of the cases of our training set 
into aggressive or indolent cases. Despite better agreement 
between the two expert readers, the diagnostic performance of 
semiquantitative tumor measurements (C/T ratio ≤ 0.25) was 
inferior to CANARY in our training set. Most importantly, the 
semiquantitative assessment missed two additional invasive 
cases.
Few previous reports have addressed the value of auto-
mated computer-aided imaging in the characterization and 
categorization of these pulmonary nodules. In a pilot study, 
histogram peaks of two-dimensional CT images were found 
to be moderately discriminative between atypical adenoma-
tous hyperplasia and bronchioloalveolar carcinoma, but with 
significant overlap.32 Volumetric analysis using density his-
tograms was more discriminative and seemed to categorize 
atypical adenomatous hyperplasia, bronchioloalveolar carci-
noma, and IA. However, the study was limited by small sam-
ple size and a lack of validation.33
Our study has several limitations. It is a pilot study and 
as such, the CANARY methodology will have to be validated 
in further independent retrospective and prospective patient 
cohorts. Prospective validation is currently ongoing. Another 
substantial limitation is the absence of true definitive standard 
test for the risk assessment of pulmonary nodules of the lung 
adenocarcinoma spectrum. The value of radiologic–pathologic 
correlation is limited for several important reasons. First, his-
tology represents a surrogate marker for patient outcomes and 
consequently CANARY-based nodule assessment ultimately 
will need to be correlated to meaningful clinical outcome 
measures such as metastatic lymph node involvement and pro-
gression-free survival. This correlation is currently ongoing 
in our validation study. Furthermore, in the absence of a stan-
dardized approach for semiquantitative assessment for histo-
pathologic evaluation, measurements of lepidic growth and 
invasion size are subject to intra- and interobserver variability. 
In that regard, it is important to consider that the comprehen-
sive (volumetric) analysis of the histologic samples is limited 
by the thickness of the tissue blocks (5–10 mm) and the num-
ber of slides/tissue block evaluated (1 × 10 μm section/block), 
whereas CANARY allows a full volumetric analysis of the 
lesion. Although this may limit the interpretation of our current 
results (radiologic–pathologic correlation), we also recognize 
that this may represent a strength of CANARY when corre-
lated to patient-centered outcome measures. In addition, we 
acknowledge that the use of different scanners and acquisition 
protocols for the CT scans, because of the retrospective nature 
of our study, may have influenced our results. We are currently 
in the process of investigating the differences in the CANARY 
signatures caused by different CT scanners and determine 
the optimal reconstruction algorithm. Another limitation of 
our study is that the natural history of screen-detected SSO 
of the adenocarcinoma spectrum remains unknown. However, 
the postsurgical biological behavior of these lesions seems to 
correlate well with the histologic predictors of outcomes that 
correlated to CANARY.
Although this pilot study is restricted to cases of his-
tologically confirmed adenocarcinomas, we hope to expand 
the use of CANARY to classify screening-detected pulmonary 
nodules. We are currently investigating whether a CANARY-
based approach can classify screening-detected pulmonary 
nodules into benign and malignant lesions and identify clini-
cally aggressive lesions of the adenocarcinoma spectrum 
using the NLST data set.
In conclusion, after further validation, the CANARY-
based noninvasive risk stratification of pulmonary nodules 
of the adenocarcinoma spectrum using a preoperative HRCT 
could be applied to guide the individualized management of 
these lesions and may offer valuable insight into the biology of 
this type of lung cancer. Furthermore, future use of CANARY 
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for the assessment of serial imaging studies to highlight both 
qualitative and quantitative longitudinal changes across serial 
imaging studies might improve its diagnostic yield beyond 
that of the current single time point evaluation.
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